Alaunos Therapeutics Inc (TCRT): ugly day all around there....maybe this...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	25
Posts	2480
Boards Moderated	0
Alias Born	03/31/2009

timmyjames

Re: gator16 post# 264

Wednesday, 06/01/2011 9:52:50 PM

Wednesday, June 01, 2011 9:52:50 PM

ugly day all around there....maybe this drops enough to take advantage of the dip

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent TCRT News

Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 12:57:34 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 02:46:36 AM
Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 09:44:55 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 09:05:27 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 05:43:20 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 09:58:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:45:52 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:47:51 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 09:30:58 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 10:30:50 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 10:25:02 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 01:00:55 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:30:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 01:00:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 12:30:01 PM
Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives • GlobeNewswire Inc. • 11/14/2023 12:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/28/2023 08:01:31 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2023 09:34:33 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/01/2023 04:20:04 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:37:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 08:16:29 PM
Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic Alternatives • GlobeNewswire Inc. • 08/14/2023 08:05:34 PM
Alaunos Therapeutics Announces Presentation at the 2nd Hawaii Global Summit on Thoracic Malignancies • GlobeNewswire Inc. • 06/29/2023 11:00:53 AM
Alaunos Therapeutics to Present Early Data from TCR-T Library Phase 1/2 Trial at 2023 American Society of Clinical Oncology Annual Meeting • GlobeNewswire Inc. • 05/25/2023 09:00:52 PM

More TCRT News

InvestorsHub NewsWire

"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM

North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM

ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover